Wall Street Zen cut shares of RxSight (NASDAQ:RXST – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning,Wall Street Zen reports. RXST has been the subject of a number of other reports. Weiss Ratings reissued a “sell (e+)” rating on shares of RxSight in a research […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.